MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30
Published August 14, 2013 · Recall initiated: June 21, 2013
Summary
FDA records drug Class II recall D-840-2013, published August 14, 2013 and initiated June 21, 2013. Recalling firm: AstraZeneca Pharmaceuticals LP; Status: Terminated; Reported quantity: 81,900 total vials; Lot: NDC 0310-321-30, lot JX109, expiration 2/2015; lot JY042, expiration 2/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Precipitate; potential for incomplete constitution upon addition of diluent.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Distributor
- USA and Puerto Rico
- Lot
- NDC 0310-321-30, lot JX109, expiration 2/2015; lot JY042, expiration 2/2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca PharmaceuticalsMarch 14, 2018
- FDATudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler,March 30, 2016
- FDANEXIUM® (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured forJune 24, 2015
- FDAVersaPharm Incorporated, Ethambutol Hydrochloride Tablets, USP 400 mg 60 tablets, Rx Only, Mfd. for VersaPharmAugust 14, 2013
- FDARifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC,August 14, 2013
- FDAWarfarin Sodium Tablets, USP 2 mg, Rx Only, 1000 Tablets per bottle, Manufactured by: Cadila Healthcare LtdAugust 14, 2013
Questions about this recall
Was MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30 recalled?
Yes. FDA published recall D-840-2013 on August 14, 2013. Reported hazard: Presence of Precipitate; potential for incomplete constitution upon addition of diluent.
What should I do if I have this product?
Voluntary: Firm initiated · Letter